Clinical Trials Browser

Unknown × Erlotinib Hydrochloride × Tumor-Agnostic × Clear all

NCT03239015 2022-03-04

Efficacy and Safety of Precision Therapy in Refractory Tumor

Phase 2 Unknown

Neoplasms

NCT00591383 2012-07-19

Phase I Study of Indibulin in Combination With Erlotinib in Advanced Solid Tumors

Phase 1 Unknown

Neoplasms